# Patent

## Title
Plant yield improvement by Ste20-like gene expression

## Abstract

The present invention concerns a method for increasing plant yield by modulating expression in a plant of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof. One such method comprises introducing into a plant a Ste20-like nucleic acid or variant thereof. The invention also relates to transgenic plants having introduced therein a Ste20-like nucleic acid or variant thereof, which plants have increased yield relative to control plants. The present invention also concerns constructs useful in the methods of the invention.

## Background
RELATED APPLICATIONS
This application is a national stage application (under 35 U.S.C. 371) of PCT/EP2006/063976 filed Jul. 6, 2006, which claims benefit of European application 05106135.6 filed Jul. 6, 2005 and U.S. Provisional application 60/697,338 filed Jul. 8, 2005.


SUBMISSION ON COMPACT DISC
The contents of the following submission on compact discs are incorporated herein by reference in its entirety: two copies of the Sequence Listing (COPY 1 and COPY 2) and a computer readable form copy of the Sequence Listing (CRF COPY), all on compact disc, each containing: file name: Sequence List-14546-00025-US, date recorded: Jan. 3, 2008, size: 112 KB.
The present invention relates generally to the field of molecular biology and concerns a method for increasing plant yield relative to control plants. More specifically, the present invention concerns a method for increasing plant yield comprising modulating expression in a plant of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof. The present invention also concerns plants having modulated expression of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof, which plants have increased yield relative to control plants. The invention also provides constructs useful in the methods of the invention.
The ever-increasing world population and the dwindling supply of arable land available for agriculture fuels research towards improving the efficiency of agriculture. Conventional means for crop and horticultural improvements utilise selective breeding techniques to identify plants having desirable characteristics. However, such selective breeding techniques have several drawbacks, namely that these techniques are typically labour intensive and result in plants that often contain heterogeneous genetic components that may not always result in the desirable trait being passed on from parent plants. Advances in molecular biology have allowed mankind to modify the germplasm of animals and plants. Genetic engineering of plants entails the isolation and manipulation of genetic material (typically in the form of DNA or RNA) and the subsequent introduction of that genetic material into a plant. Such technology has the capacity to deliver crops or plants having various improved economic, agronomic or horticultural traits. A trait of particular economic interest is yield, necessarily related to a specified crop, area and/or period of time. Yield is normally defined as the measurable produce of economic value from a crop. This may be defined in terms of quantity and/or quality. Yield is directly dependent on several factors, for example, the number and size of the organs, plant architecture (for example, the number of branches), seed production and more. Root development, nutrient uptake and stress tolerance may also be important factors in determining yield. Optimizing one of the abovementioned factors may therefore contribute to increasing crop yield.
Plant biomass is yield for forage crops like alfalfa, silage corn and hay. Many proxies for yield have been used in grain crops. Chief amongst these are estimates of plant size. Plant size can be measured in many ways depending on species and developmental stage, but include total plant dry weight, above-ground dry weight, above-ground fresh weight, leaf area, stem volume, plant height, rosette diameter, leaf length, root length, root mass, tiller number and leaf number. Many species maintain a conservative ratio between the size of different parts of the plant at a given developmental stage. These allometric relationships are used to extrapolate from one of these measures of size to another (e.g. Tittonell et al 2005 Agric Ecosys & Environ 105: 213). Plant size at an early developmental stage will typically correlate with plant size later in development. A larger plant with a greater leaf area can typically absorb more light and carbon dioxide than a smaller plant and therefore will likely gain a greater weight during the same period (Fasoula & Tollenaar 2005 Maydica 50:39). This is in addition to the potential continuation of the micro-environmental or genetic advantage that the plant had to achieve the larger size initially. There is a strong genetic component to plant size and growth rate (e.g. ter Steege et al 2005 Plant Physiology 139:1078), and so for a range of diverse genotypes plant size under one environmental condition is likely to correlate with size under another (Hittalmani et al 2003 Theoretical Applied Genetics 107:679). In this way a standard environment is used as a proxy for the diverse and dynamic environments encountered at different locations and times by crops in the field.
Harvest index, the ratio of seed yield to above-ground dry weight, is relatively stable under many environmental conditions and so a robust correlation between plant size and grain yield can often be obtained (e.g. Rebetzke et al 2002 Crop Science 42:739). These processes are intrinsically linked because the majority of grain biomass is dependent on current or stored photosynthetic productivity by the leaves and stem of the plant (Gardener et al 1985 Physiology of Crop Plants. Iowa State University Press, pp 68-73) Therefore, selecting for plant size, even at early stages of development, has been used as an indicator for future potential yield (e.g. Tittonell et al 2005 Agric Ecosys & Environ 105: 213). When testing for the impact of genetic differences on stress tolerance, the ability to standardize soil properties, temperature, water and nutrient availability and light intensity is an intrinsic advantage of greenhouse or plant growth chamber environments compared to the field. However, artificial limitations on yield due to poor pollination due to the absence of wind or insects, or insufficient space for mature root or canopy growth, can restrict the use of these controlled environments for testing yield differences. Therefore, measurements of plant size in early development, under standardized conditions in a growth chamber or greenhouse, are standard practices to provide indication of potential genetic yield advantages.
Seed yield is a particularly important trait since the seeds of many plants are important for human and animal nutrition. Crops such as, corm, rice, wheat, canola and soybean account for over half the total human caloric intake, whether through direct consumption of the seeds themselves or through consumption of meat products raised on processed seeds. They are also a source of sugars, oils and many kinds of metabolites used in industrial processes. Seeds contain an embryo (the source of new shoots and roots) and an endosperm (the source of nutrients for embryo growth during germination and during early growth of seedlings). The development of a seed involves many genes, and requires the transfer of metabolites from the roots, leaves and stems into the growing seed. The endosperm, in particular, assimilates the metabolic precursors of carbohydrates, oils and proteins and synthesizes them into storage macromolecules to fill out the grain. The ability to increase plant seed yield, whether through seed number, seed biomass, seed development, seed filling, or any other seed-related trait would have many applications in agriculture, and even many non-agricultural uses such as in the biotechnological production of substances such as pharmaceuticals, antibodies or vaccines.
Ste20 is a Ser/Thr kinase belonging to the group of MAP4 kinases (MAP4Ks, MAP kinase kinase kinase kinases, or MAP3K kinases), and was for the first time isolated from yeast. MAP4K are kinases that activate MAP kinase cascades by directly phosphorylating MAP3Ks. A recent phylogenetic study discriminated 6 major groups of MAP4Ks, among which the STE20/PAK group of MAP4Ks (Champion et al., Trends Plant Sci. 9, 123-129, 2004). Most of the MAP4Ks have an N-terminal catalytic domain, although plant proteins homologous to Ste20 may have a different organisation. Members of the Ste20 group of kinases are believed to act as regulators of MAP kinase cascades (Dan et al., Trends Cell Biol. 11, 220-230, 2001), and are believed to act in particular upon MAP3 Kinases of the MEKK and Raf types, downstream of G-proteins (Champion et al., 2004). Yeast Ste20 plays a role in various signalling pathways, for example Candida Ste20 was shown to be involved in pheromone signalling, invasive growth, hypertonic stress response, cell wall integrity and in binding of CDC42, required for polarized morphogenesis (Calcagno et al., Yeast 21, 557-568, 2004). In Drosophila, the Ste20 homologue Hippo is reported to be involved in cell cycle progression (Udan et al., Nat. Cell Biol. 5, 853-855, 2003). In general, the effects of STE20/PAK directed signalling appear to be nuclear events that influence gene expression on the one hand, and cytoskeletal events that impact upon cellular dynamics (Bagrodia and Cerione, Trends Cell Biol. 9, 350-355, 1999). Although Ste20 and related proteins are relatively well studied in yeast, Drosophila and in mammalian cells, little or nothing is known about the plant homologues of yeast Ste20. Leprince et al. (Biochim. Biophys. Acta 1444, 1-13, 1999) have characterised a MAP4K from Brassica napus. Its expression seemed regulated by the cell cycle and transcripts were reported to most abundant in roots, siliques and flower buds. However, no mutants or transgenic plants were described.
Surprisingly, it has now been found that modulating expression in a plant of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof gives plants having increased yield relative to control plants. Preferably, the Ste20-like polypeptide or a homologue thereof is of plant origin.
Therefore, the invention provides a method for increasing plant yield, comprising modulating expression in a plant of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof.
Advantageously, performance of the methods according to the present invention results in plants having increased yield, particularly seed yield, relative to control plants.
The choice of control plants is a routine part of an experimental setup and may include corresponding wild type plants or corresponding plants without the gene of interest. The control plant is typically of the same plant species or even of the same variety as the plant to be compared. The control plant may also be a nullizygote of the plant to be compared. Nullizygotes are individuals missing the transgene by segregation. A “control plant” as used herein refers not only to whole plants, but also to plant parts, including seeds and seed parts.
A “reference”, “reference plant”, “control”, “control plant”, “wild type” or “wild type plant” is in particular a cell, a tissue, an organ, a plant, or a part thereof, which was not produced according to the method of the invention. Accordingly, the terms “wild type”, “control” or “reference” are exchangeable and can be a cell or a part of the plant such as an organelle or tissue, or a plant, which was not modified or treated according to the herein described method according to the invention. Accordingly, the cell or a part of the plant such as an organelle or a plant used as wild type, control or reference corresponds to the cell, plant or part thereof as much as possible and is in any other property but in the result of the process of the invention as identical to the subject matter of the invention as possible. Thus, the wild type, control or reference is treated identically or as identical as possible, saying that only conditions or properties might be different which do not influence the quality of the tested property. That means in other words that the wild type denotes (1) a plant, which carries the unaltered or not modulated form of a gene or allele or (2) the starting material/plant from which the plants produced by the process or method of the invention are derived.
Preferably, any comparison between the wild type plants and the plants produced by the method of the invention is carried out under analogous conditions. The term “analogous conditions” means that all conditions such as, for example, culture or growing conditions, assay conditions (such as buffer composition, temperature, substrates, pathogen strain, concentrations and the like) are kept identical between the experiments to be compared.
The “reference”, “control”, or “wild type” is preferably a subject, e.g. an organelle, a cell, a tissue, a plant, which was not modulated, modified or treated according to the herein described process of the invention and is in any other property as similar to the subject matter of the invention as possible. The reference, control or wild type is in its genome, transcriptome, proteome or metabolome as similar as possible to the subject of the present invention. Preferably, the term “references-” “control-” or “wild type-”-organelle, -cell, -tissue or plant, relates to an organelle, cell, tissue or plant, which is nearly genetically identical to the organelle, cell, tissue or plant, of the present invention or a part thereof preferably 95%, more preferred are 98%, even more preferred are 99.00%, in particular 99.10%, 99.30%, 99.50%, 99.70%, 99.90%, 99.99%, 99, 999% or more. Most preferable the “reference”, “control”, or “wild type” is preferably a subject, e.g. an organelle, a cell, a tissue, a plant, which is genetically identical to the plant, cell organelle used according to the method of the invention except that nucleic acid molecules or the gene product encoded by them are changed, modulated or modified according to the inventive method.
In case, a control, reference or wild type differing from the subject of the present invention only by not being subject of the method of the invention can not be provided, a control, reference or wild type can be a plant in which the cause for the modulation of the activity conferring the increase of the metabolites as described under examples.
The term “yield” in general means a measurable produce of economic value, necessarily related to a specified crop, to an area, and to a period of time. Individual plant parts directly contribute to yield based on their number, size and/or weight. Whereas the actual yield is the yield per acre for a crop and year, which is determined by dividing total production (includes both harvested and appraised production) by planted acres.
The terms “increase”, “improving” or “improve” are interchangeable and shall mean in the sense of the application at least a 5%, 6%, 7%, 8%, 9% or 10%, preferably at least 15% or 20%, more preferably 25%, 30%, 35% or 40% more yield and/or growth in comparison to the wild type plant as defined herein.
The increase referred to the activity of the polypeptide amounts in a cell, a tissue, a organelle, an organ or an organism or a part thereof preferably to at least 5%, preferably to at least 10% or at to least 15%, especially preferably to at least 20%, 25%, 30% or more, very especially preferably are to at least 40%, 50% or 60%, most preferably are to at least 70% or more in comparison to the control, reference or wild type.
The term “increased yield” as defined herein is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground.
In particular, such harvestable parts are seeds and leafy biomass, and performance of the methods of the invention results in plants having increased leafy biomass and increased seed yield relative to the seed yield of control plants.
Increased seed yield may manifest itself as one or more of the following: a) an increase in seed biomass (total seed weight) which may be on an individual seed basis and/or per plant and/or per hectare or acre; b) increased number of flowers per plant; c) increased number of (filled) seeds; d) increased seed filling rate (which is expressed as the ratio between the number of filled seeds divided by the total number of seeds; e) increased harvest index, which is expressed as a ratio of the yield of harvestable parts, such as seeds, divided by the total biomass; and f) increased thousand kernel weight (TKW), which is extrapolated from the number of filled seeds counted and their total weight. An increased TKW may result from an increased seed size and/or seed weight, and may also result from an increase in embryo and/or endosperm size.
The term “expression” or “gene expression” means the appearance of a phenotypic trait as a consequence of the transcription of a specific gene or specific genes. The term “expression” or “gene expression” in particular means the transcription of a gene or genes into structural RNA (rRNA, tRNA) or mRNA with subsequent translation of the latter into a protein. The process includes transcription of DNA, processing of the resulting mRNA product and its translation into an active protein.
The term “modulation” means in relation to expression or gene expression, a process in which the expression level is changed by said gene expression in comparison to the control plant, preferably the expression level is increased. The original, unmodulated expression may be of any kind of expression of a structural RNA (rRNA, tRNA) or mRNA with subsequent translation. The term “modulating the activity” shall mean any change of the expression of the inventive nucleic acid sequences or encoded proteins, which leads to increased yield and/or increased growth of the plants.
An increase in seed yield may also be manifested as an increase in seed size and/or seed volume, which may also influence the composition of seeds (including oil, protein and carbohydrate total content and composition). Furthermore, an increase in seed yield may also manifest itself as an increase in seed area and/or seed length and/or seed width and/or seed perimeter. Increased yield may also result in modified architecture, or may occur because of modified architecture.
Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants per hectare or acre, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per hectare or acre, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. An increase in yield may also result in modified architecture, or may occur as a result of modified architecture.
According to a preferred feature, performance of the methods of the invention result in plants having increased yield, particularly seed yield. Therefore, according to the present invention, there is provided a method for increasing plant yield, which method comprises modulating expression in a plant of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof.
Since the transgenic plants according to the present invention have increased yield, it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of corresponding wild type plants at a corresponding stage in their life cycle. The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors such as early vigour, growth rate, flowering time and speed of seed maturation. An increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of rice plants followed by, for example, the sowing and optional harvesting of soy bean, potato or any other plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per acre (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others.
According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate or increased yield in comparison to control plants. Therefore, according to the present invention, there is provided a method for increasing yield and/or the growth rate of plants, which method comprises modulating, preferably increasing, expression in a plant of a nucleic acid encoding a Ste20-like protein.
An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11% or 10% or less in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the typical stresses to which a plant may be exposed. These stresses may be the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Typical abiotic or environmental stresses include temperature stresses caused by atypical hot or cold/freezing temperatures; salt stress; water stress (drought or excess water). Chemicals may also cause abiotic stresses. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects. In another preferred embodiment of the invention an increase in yield and/or growth rate occurs according to the method of invention under non-stress or mild abiotic or biotic stress conditions, preferably on non-stress or mild abiotic stress conditions.
The abovementioned growth characteristics may advantageously be modified in any plant.
The term “plant” as used herein encompasses whole plants, ancestors and progeny of the plants, plant cells and plant parts, including seeds, shoots, stems, leaves, roots (including tubers), flowers, and tissues and organs, wherein each of the aforementioned comprise the gene/nucleic acid of interest. The term “plant” also encompasses suspension cultures, callus tissue, embryos, meristematic regions, gametophytes, sporophytes, pollen and microspores, again wherein each of the aforementioned comprise the gene/nucleic acid of interest.
Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs selected from the list comprising Acer spp., Actinidia spp., Abelmoschus spp., Agropyron spp., Allium spp., Amaranthus spp., Ananas comosus, Annona spp., Apium graveolens, Arabidopsis thaliana, Archis spp, Artocarpus spp., Asparagus officinalis, Avena sativa, Averrhoa carambola, Benincasa hispida, Bertholletia excelsea, Beta vulgaris, Brassica spp., Cadaba farinosa, Camellia sinensis, Canna indica, Capsicum spp., Carex elata, Carica papaya, Carissa macrocarpa, Carya spp., Carthamus tinctorius, Castanea spp., Cichorium endivia, Cinnamomum spp., Citrullus lanatus, Citrus spp., Cocos spp., Coffea spp., Colocasia esculenta, Cola spp., Coriandrum sativum, Corylus spp., Crataegus spp., Crocus sativus, Cucurbita spp., Cucumis spp., Cynara spp., Daucus carota, Desmodium spp., Dimocarpus longan, Dioscorea spp., Diospyros spp., Echinochloa spp., Eleusine coracana, Eriobotrya japonica, Eugenia uniflora, Fagopyrum spp., Fagus spp., Ficus carica, Fortunelia spp., Fragaria spp., Ginkgo biloba, Glycine spp., Gossypium hirsutum, Helianthus spp., Hemerocallis fulva, Hibiscus spp., Hordeum spp., Ipomoea batatas, Juglans spp., Lactuca sativa, Lathyrus spp., Lens culinaris, Linum usitatissimum, Litchi chinensis, Lotus spp., Luffa acutangula, Lupinus spp., Luzula sylvatica, Macrotyloma spp., Malus spp., Malpighia emarginata, Mammea americana, Mangifera indica, Manihot spp., Manilkara zapota, Medicago sativa, Melilotus spp., Mentha spp., Momordica spp., Morus nigra, Musa spp., Nicotiana spp., Olea spp., Opuntia spp., Omithopus spp., Oryza spp., Panicum miliaceum, Passiflora edulis, Pastinaca sativa, Persea spp., Petroselinum crispum, Phaseolus spp., Phoenix spp., Physalis spp., Pinus spp., Pistacia vera, Pisum spp., Poa spp., Populus spp., Prosopis spp., Prunus spp., Psidium spp., Punica granatum, Pyrus communis, Quercus spp., Raphanus sativus, Rheum rhabarbarum, Ribes spp., Rubus spp., Saccharum spp., Sambucus spp., Secale cereale, Sesamum spp., Sinapis sp., Solanum spp., Sorghum bicolor, Spinacia spp., Syzygium spp., Tamarindus indica, Theobroma cacao, Trifolium spp., Triticosecale rimpaui, Triticum spp., Tropaeolum minus, Tropaeolum majus, Vaccinium spp., Vicia spp., Vigna spp., Viola odorata, Vitis spp., Zea mays, Zizania palustris, Ziziphus spp., amongst others. According to a preferred embodiment of the present invention, the plant is a crop plant such as soybean, sunflower, canola, alfalfa, rapeseed, cotton, tomato, potato or tobacco. Further preferably, the plant is a monocotyledonous plant, such as sugar cane. More preferably the plant is a cereal, such as rice, maize, wheat, barley, millet, rye, sorghum or oats.
Other advantageous plants are selected from the group consisting of Asteraceae such as the genera Helianthus, Tagetes e.g. the species Helianthus annus [sunflower], Tagetes lucida, Tagetes erecta or Tagetes tenuifolia [Marigold], Brassicaceae such as the genera Brassica, Arabadopsis e.g. the species Brassica napus, Brassica rapa ssp. [canola, oilseed rape, turnip rape] or Arabidopsis thaliana. Fabaceae such as the genera Glycine e.g. the species Glycine max, Soja hispida or Soja max [soybean]. Linaceae such as the genera Linum e.g. the species Linum usitatissimum, [flax, linseed]; Poaceae such as the genera Hordeum, Secale, Avena, Sorghum, Oryza, Zea, Triticum e.g. the species Hordeum vulgare [barley]; Secale cereale [rye], Avena sativa, Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena hybrida [oat], Sorghum bicolor [Sorghum, millet], Oryza sativa, Oryza latifolia [rice], Zea mays [corn, maize] Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybemum, Triticum macha, Triticum sativum or Triticum vulgare [wheat, bread wheat, common wheat]; Solanaceae such as the genera Solanum, Lycopersicon e.g. the species Solanum tuberosum [potato], Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme, Solanum integrifolium or Solanum lycopersicum [tomato].
The term “Ste20-like polypeptide or homologue thereof” as defined herein refers to a MAP4K polypeptide, preferably of plant origin, comprising an N-terminal Ser/Thr kinase domain (matching the SMART database entry SM00220, InterPro accession IPR002290). The kinase domain in SEQ ID NO: 2 starts at Y15 and ends at F293, and comprises the ProSite Ser/Thr protein kinase pattern PS00108:

    [LIVMFYC]-x-[HY]-x-D-[LIVMFY]-K-x(2)-N-[LIVMFYCT](3), wherein the first x is missing. Preferably, the Ste20-like polypeptide or homologue thereof comprises the Ste20 signature sequence:













(SEQ ID NO: 6; Dan et al., 2001)




G(T/N)P(Y/C/R)(W/R)MAPE(V/K),






    more preferably it comprises the sequence motif:











(S/H/N)(I/L)(V/I/L/M)(S/K)(S/H/T/A/I/V)(S/G/V/A)(F/Y)(P/Q)(S/N/D/E)G,
(SEQ ID NO: 7)







    most preferably the Ste20-like polypeptide or homologue thereof comprises at least one of the following sequence motifs:












SEQ ID NO: 8,
(V/I)HSH(T/N/V)GY(G/S)(F/I)


 



SEQ ID NO: 9,
RPPLSHLPP(L/S)KS


 



SEQ ID NO: 10,
RRISGWNF






At the C-terminal end of the protein, a coiled coil motif may be present (K450 to T477 in SEQ ID NO: 2).

The term “domain” refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are essential in the structure, the stability, or the activity of a protein. Identified by their high degree of conservation in aligned sequences of a family of protein homologues, they can be used as identifiers to determine if any polypeptide in question belongs to a previously identified polypeptide family (in this case, the family of Ste20-like proteins). The term “motif” refers to a short conserved region in a protein sequence. Motifs are frequently highly conserved parts of domains, but may also include only part of the domain, or be located outside of conserved domain (if all of the amino acids of the motif fall outside of a defined domain).
Specialist databases exist for the identification of domains. The kinase domain in a Ste20-like protein may be identified using, for example, SMART (Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nudeic Acids Res 30, 242-244), Interpro (Mulder et al., (2003) Nud. Acids. Res. 31, 315-318), Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp 53-61, AAAIPress, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004)) or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002)). A set of tools for in silico analysis of protein sequences is available on the ExPASY proteomics server (hosted by the Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788 (2003)).
By aligning other protein sequences with SEQ ID NO: 2, the corresponding Ste20 signature sequence, the kinase domain and other sequence motifs detailed above may easily be identified. In this way, Ste20-like polypeptides or homologues thereof (encompassing orthologues and paralogues) may readily be identified, using routine techniques well known in the art, such as by sequence alignment. Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the alignment of two complete sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information. Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul. 10; 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full length sequences for the identification of homologues, specific domains (such as the kinase domain) may be used as well. The sequence identity values, which are indicated above as a percentage were determined over the entire conserved domain or nucleic acid or amino acid sequence using the programs mentioned above using the default parameters.
Examples of Ste20-like polypeptides or homologues thereof include the Arabidopsis sequences SEQ ID NO: 12 (corresponding to At5g14720, encoded by GenBank accession number AAL38867), SEQ ID NO: 14 (At1g70430, GenBank NP—177200), SEQ ID NO: 16 (At1g23700, GenBank NP—173782), SEQ ID NO: 18 (At1g79640, GenBank NP—178082), SEQ ID NO: 20 (At4g10730, GenBank NP—192811), SEQ ID NO: 22 (At4g24100, GenBank NP—194141); the rice sequences SEQ ID NO: 24 (GenBank XP—469286, the rice orthologue of SEQ ID NO: 2), SEQ ID NO: 26 (GenBank BAD37346), SEQ ID NO: 28 (GenBank XP—468215), SEQ ID NO: 30 (GenBank AAL54869), SEQ ID NO: 32 (GenBank NP—912431) and the Medicago sequence SEQ ID NO: 34 (orthologue of SEQ ID NO: 2).
It is to be understood that sequences falling under the definition of “Ste20-like polypeptide or homologue thereof” are not to be limited to the sequences represented by SEQ ID NO: 2, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 32 or SEQ ID NO: 34, but that any polypeptide comprising a N-terminal kinase domain as defined above, the Ste20 signature sequence and preferably also one or more of the sequence motifs detailed in SEQ ID NO: 7, 8, 9 and 10, may be suitable for use in the methods of the invention. In a preferred embodiment, the homologue used in the methods of the present invention is an othologue of SEQ ID NO: 2.
An assay may be carried out to determine Ste20-like activity. For example to determine the kinase activity, several assays are available and well known in the art (for example Current Protocols in Molecular Biology, Volumes 1 and 2, Ausubel et al. (1994), Current Protocols). The Ste20-like protein is a MAP4K kinase involved in signal transduction. For several organisms, the substrate of Ste20 was identified as Ste11p (Drogen et al., Current Biology 10, 630-639, 2000). Besides in vit phosphorylation of the Ste11 p protein, Ste20 was also shown to phosphorylate histone H2B (Ahn et al., Cell 120, 25-36, 2005). Buffer composition, ionic strength, and pH may be optimized starting from a standard kinase assay mixture. A standard 5× Kinase Buffer generally contains 5 mg/ml BSA (Bovine Serum Albumin preventing kinase adsorption to the assay tube), 150 mM Tris-Cl (pH 7.5), 100 mM MgCl2. Divalent cations are required for most tyrosine kinases, although some tyrosine kinases (for example, insulin-, IGF-1-, and PDGF receptor kinases) require MnCl2 instead of MgCl2 (or in addition to MgCl2). The optimal concentrations of divalent cations must be determined empirically for each protein kinase. A commonly used donor for the phophoryl group is radio-labelled [gamma-32P]ATP (normally at 0.2 mM final concentration). The amount of 32P incorporated in the peptides may be determined by measuring activity on the nitrocellulose dry pads in a scintillation counter.
Furthermore, expression of the Ste20-like protein or of a homologue thereof in plants, and in particular in rice, has the effect of increasing yield of the transgenic plant when compared to control plants, wherein increased yield comprises at least one of: total weight of seeds, number of filled seeds and harvest index.
“Homologues” of a protein encompass peptides, oligopeptides, polypeptides, proteins and enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified protein in question and having similar biological and functional activity as the unmodified protein from which they are derived.
Encompassed by the term “homologues” are orthologous sequences and paralogous sequences, two special forms of homology which encompass evolutionary concepts used to describe ancestral relationships of genes. Paralogues are genes within the same species that have originated through duplication of an ancestral gene and orthologues are genes from different organisms that have originated through speciation.
Orthologues and paralogues may easily be found by performing a so-called reciprocal blast search. This may be done by a first BLAST involving BLASTing a query sequence (for example, SEQ ID NO: 1 or SEQ ID NO: 2) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) may be used when starting from a nucleotide sequence and BLASTP or TBLASTN (using standard default values) may be used when starting from a protein sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is SEQ ID NO: 1 or SEQ ID NO: 2, the second BLAST would therefore be against Arabidopsis sequences). The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the second BLAST is from the same species as from which the query sequence is derived; an orthologue is identified if a high-ranking hit is not from the same species as from which the query sequence is derived. Preferred orthologues are orthologues of SEQ ID NO: 1 or SEQ ID NO: 2. High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. Preferably the score is greater than 50, more preferably greater than 100; and preferably the E-value is less than e-5, more preferably less than e-6. In the case of large families, ClustalW may be used, followed by the generation of a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. Examples of sequences orthologous to SEQ ID NO: 2 include SEQ ID NO: 24 and SEQ ID NO: 34. Examples of paralogues of SEQ ID NO: 2 include SEQ ID NO: 12 (At5g14720) and SEQ ID NO: 20 (At4g10730).
Preferably, the kinase domains of Ste20-like proteins useful in the methods of the present invention have, in increasing order of preference, at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence identity to the kinase domain of the Ste20 protein of SEQ ID NO: 2. An example detailing the identification of homologues is given in Example 1. The matrix shown in Example 1 (Table 4) shows similarities and identities (in bold) over the full-length of the protein. In case only specific domains are compared, the identity or similarity may be higher among the different proteins (Table 5: comparison of the kinase domains only).
A Ste20-like polypeptide or homologue thereof is encoded by a Ste20-like nucleic acid/gene. Therefore the term “Ste20-like nucleic acid/gene” as defined herein is any nucleic acid/gene encoding a Ste20-like polypeptide or a homologue thereof as defined above.
Examples of Ste20-like nucleic acids include but are not limited to those represented by any one of SEQ ID NO: 3, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 or SEQ ID NO: 33.
Ste20-like nucleic acids/genes and variants thereof may be suitable in practising the methods of the invention. Variant Ste20-like nucleic acid/genes include portions of a Ste20-like nucleic acid/gene, splice variants, allelic variants and/or nucleic acids capable of hybridising with a Ste20-like nucleic acid/gene.
The term portion as defined herein refers to a piece of DNA encoding a polypeptide comprising the Ste20 signature sequence G(T/N)P(Y/C/R)(W/R)MAPE(V/K) (SEQ ID NO: 6) and a N-terminal Ser/Thr kinase domain as defined above. A portion may be prepared, for example, by making one or more deletions to a Ste20-like nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non-coding) sequences in order to, for example, produce a protein that combines several activities. When fused to other coding sequences, the resulting polypeptide produced upon translation may be bigger than that predicted for the Ste20-like fragment. The portion is typically at least 300, 400, 500, 600 or 700 nucleotides in length, preferably at least 750, 900, 850, 900 or 950 nucleotides in length, more preferably at least 1000, 1100, 1200 or 1300 nucleotides in length and most preferably at least 1350, 1400 or 1450 nucleotides in length. Preferably, the portion is a portion of a nucleic add as represented by any one of SEQ ID NO: 1, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 or SEQ ID NO: 33. Most preferably the portion of a nucleic add is as represented by SEQ ID NO: 1.
The terms “fragment”, “fragment of a sequence” or “part of a sequence” “portion” or “portion thereof” mean a truncated sequence of the original sequence referred to. The truncated sequence (nucleic acid or protein sequence) can vary widely in length; the minimum size being a sequence of sufficient size to provide a sequence with at least a comparable function and/or activity of the original sequence referred to or hybidizing with the nucleic acid molecule of the invention or used in the process of the invention under stringend conditions, while the maximum size is not critical. In some applications, the maximum size usually is not substantially greater than that required to provide the desired activity and/or function(s) of the original sequence. A comparable function means at least 40%, 45% or 50%, preferably at least 60%, 70%, 80% or 90% or more of the original sequence.
Another variant of a Ste20-like nucleic acid/gene is a nucleic acid capable of hybridising under reduced stringency conditions, preferably under stringent conditions, with a Ste20-like nucleic acid/gene as hereinbefore defined or with a portion as defined hereinabove.
Hybridising sequences useful in the methods of the present invention encode a polypeptide having a Ste20 signature sequence G(T/N)P(Y/C/R)(W/R)MAPE(V/K) (SEQ ID NO: 6) and a N-terminal Ser/Thr kinase domain as defined above and having substantially the same biological activity as the Ste20-like protein represented by SEQ ID NO: 2 or homologues thereof. The hybridizing sequence is typically at least 800 nucleotides in length, preferably at least 1000 nucleotides in length, more preferably at least 1200 nucleotides in length and most preferably at least 1400 nucleotides in length.
Preferably, the hybridising sequence is one that is capable of hybridising to a nucleic acid as represented by (or to probes derived from) SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 or SEQ ID NO: 33, or to a portion of any of the aforementioned sequences, a portion being as defined above. Most preferably the hybridising sequence is capable of hybridising to SEQ ID NO: 1, or to portions (or probes) thereof. Methods for designing probes are well known in the art. Probes are generally less than 1000 bp, 900 bp, 800 bp, 700 bp, 600 bp in length, preferably less than 500 bp, 400 bp, 300 bp 200 bp or 100 bp in length. Commonly, probe lengths for DNA-DNA hybridisations such as Southern blotting, vary between 100 and 500 bp, whereas the hybridising region in probes for DNA-DNA hybridisations such as in PCR amplification generally are shorter than 50 but longer than 10 nucleotides, preferably they are 15, 20, 25, 30, 35, 40, 45 or 50 bp in length.
The term “hybridisation” as defined herein is a process wherein substantially homologous complementary nucleotide sequences anneal to each other. The hybridisation process can occur entirely in solution, i.e. both complementary nucleic acids are in solution. The hybridisation process can also occur with one of the complementary nucleic acids immobilised to a matrix such as magnetic beads, Sepharose beads or any other resin. The hybridisation process can furthermore occur with one of the complementary nucleic acids immobilised to a solid support such as a nitro-cellulose or nylon membrane or immobilised by e.g. photolithography to, for example, a siliceous glass support (the latter known as nucleic acid arrays or micro-arrays or as nucleic acid chips). In order to allow hybridisation to occur, the nucleic acid molecules are generally thermally or chemically denatured to melt a double strand into two single strands and/or to remove hairpins or other secondary structures from single stranded nucleic acids.
The term “stringency” refers to the conditions under which a hybridisation takes place. The stringency of hybridisation is influenced by conditions such as temperature, salt concentration, ionic strength and hybridisation buffer composition. Generally, low stringency conditions are selected to be about 30° C. lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. Medium stringency conditions are when the temperature is 20° C. below Tm, and high stringency conditions are when the temperature is 10° C. below Tm. High stringency hybridisation conditions are typically used for isolating hybridising sequences that have high sequence similarity to the target nucleic acid sequence. However, nucleic acids may deviate in sequence and still encode a substantially identical polypeptide, due to the degeneracy of the genetic code. Therefore medium stringency hybridisation conditions may sometimes be needed to identify such nucleic acid molecules.
The Tm is the temperature under defined ionic strength and pH, at which 50% of the target sequence hybridises to a perfectly matched probe. The Tm is dependent upon the solution conditions and the base composition and length of the probe. For example, longer sequences hybridise specifically at higher temperatures. The maximum rate of hybridisation is obtained from about 16° C. up to 32° C. below Tm. The presence of monovalent cations in the hybridisation solution reduce the electrostatic repulsion between the two nucleic acid strands thereby promoting hybrid formation; this effect is visible for sodium concentrations of up to 0.4M (for higher concentrations, this effect may be ignored). Formamide reduces the melting temperature of DNA-DNA and DNA-RNA duplexes with 0.6 to 0.7° C. for each percent formamide, and addition of 50% formamide allows hybridisation to be performed at 30 to 45° C., though the rate of hybridisation will be lowered. Base pair mismatches reduce the hybridisation rate and the thermal stability of the duplexes. On average and for large probes, the Tm decreases about 1° C. per % base mismatch. The Tm may be calculated using the following equations, depending on the types of hybrids:

    1). DNA-DNA hybrids (Meinkoth and Wahl, Anal. Biochem., 138: 267-284, 1984):

Tm=81.5° C.+16.6×log10[Na+]a+0.41×%[G/Cb]−500×[Lc]−1−0.61×% formamide

    2). DNA-RNA or RNA-RNA hybrids:

Tm=79.8+18.5(log10[Na+]a)+0.58 (% G/Cb)+11.8(% G/Cb)2−820/Lc 

    3). oligo-DNA or oligo-RNAd hybrids:
    
        For <20 nucleotides: Tm=2 (In)
        For 20-35 nucleotides: Tm=22+1.46 (In)
    
    
    a or for other monovalent cation, but only accurate in the 0.01-0.4 M range.
    b only accurate for % GC in the 30% to 75% range.
    c L=length of duplex in base pairs.
    d Oligo, oligonucleotide; In, effective length of primer=2×(no. of G/C)+(no. of A/T).


Non-specific binding may be controlled using any one of a number of known techniques such as, for example, blocking the membrane with protein containing solutions, additions of heterologous RNA, DNA, and SDS to the hybridisation buffer, and treatment with Rnase. For non-homologous probes, a series of hybridizations may be performed by varying one of (i) progressively lowering the annealing temperature (for example from 68° C. to 42° C.) or (ii) progressively lowering the formamide concentration (for example from 50% to 0%). The skilled artisan is aware of various parameters which may be altered during hybridisation and which will either maintain or change the stringency conditions.
Besides the hybridisation conditions, specificity of hybridisation typically also depends on the function of post-hybridisation washes. To remove background resulting from non-specific hybridisation, samples are washed with dilute salt solutions. Critical factors of such washes include the ionic strength and temperature of the final wash solution: the lower the salt concentration and the higher the wash temperature, the higher the stringency of the wash. Wash conditions are typically performed at or below hybridisation stringency. A positive hybridisation gives a signal that is at least twice of that of the background. Generally, suitable stringent conditions for nucleic acid hybridisation assays or gene amplification detection procedures are as set forth above. More or less stringent conditions may also be selected. The skilled artisan is aware of various parameters which may be altered during washing and which will either maintain or change the stringency conditions.
For example, typical high stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 65° C. in 1×SSC or at 42° C. in 1×SSC and 50% formamide, followed by washing at 65° C. in 0.3×SSC. Examples of medium stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 50° C. in 4×SSC or at 40° C. in 6×SSC and 50% formamide, followed by washing at 50° C. in 2×SSC. The length of the hybrid is the anticipated length for the hybridising nucleic acid. When nucleic acids of known sequence are hybridised, the hybrid length may be determined by aligning the sequences and identifying the conserved regions described herein. 1×SSC is 0.15M NaCl and 15 mM sodium citrate; the hybridisations and washes may additionally include 5×Denhardt's reagent, 0.5-1.0% SDS, 100 μg/ml denatured, fragmented salmon sperm DNA, 0.5% sodium pyrophosphate.
For the purposes of defining the level of stringency, reference can conveniently be made to Sambrook et al. (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York, or to Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989 and yearly updates).
Also useful in the methods of the invention are nucleic acids encoding homologues of the amino acid sequence represented by SEQ ID NO 2.
A homologue may be in the form of a “substitutional variant” of a protein, i.e. where at least one residue in an amino acid sequence has been removed and a different residue inserted in its place. Amino acid substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the polypeptide; insertions will usually be of the order of about 1 to 10 amino acid residues. Preferably, amino acid substitutions comprise conservative amino acid substitutions. To produce such homologues, amino acids of the protein may be replaced by other amino acids having similar properties (such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break α-helical structures or β-sheet structures). Conservative substitution tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company and Table 1 below).







TABLE 1







Examples of conserved amino acid substitutions










Residue
Conservative Substitutions







Ala
Ser



Arg
Lys



Asn
Gln; His



Asp
Glu



Gln
Asn



Cys
Ser



Glu
Asp



Gly
Pro



His
Asn; Gln



Ile
Leu, Val



Leu
Ile; Val



Lys
Arg; Gln



Met
Leu; Ile



Phe
Met; Leu; Tyr



Ser
Thr; Gly



Thr
Ser; Val



Trp
Tyr



Tyr
Trp; Phe



Val
Ile; Leu










A homologue may also be in the form of an “insertional variant” of a protein, i.e. where one or more amino acid residues are introduced into a predetermined site in a protein. Insertions may comprise N-terminal and/or C-terminal fusions as well as intra-sequence insertions of single or multiple amino acids. Generally, insertions within the amino acid sequence will be smaller than N- or C-terminal fusions, of the order of about 1 to 10 residues. Examples of N- or C-terminal fusion proteins or peptides include the binding domain or activation domain of a transcriptional activator as used in the yeast two-hybrid system, phage coat proteins, (histidine)-6-tag, glutathione S-transferase-tag, protein A, maltose-binding protein, dihydrofolate reductase, Tag-100 epitope, c-myc epitope, FLAG-epitope, lacZ, CMP (calmodulin-binding peptide), HA epitope, protein C epitope and VSV epitope.
Homologues in the form of “deletion variants” of a protein are characterised by the removal of one or more amino acids from a protein.
Amino acid variants of a protein (substitution-, deletion- and/or insertion-variants) may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulations. Methods for the manipulation of DNA sequences to produce substitution, insertion or deletion variants of a protein are well known in the art. For example, techniques for making substitution mutations at predetermined sites in DNA are well known to those skilled in the art and include M13 mutagenesis, T7-Gen in vito mutagenesis (USB, Cleveland, Ohio), QuickChange Site Directed mutagenesis (Stratagene, San Diego, Calif.), PCR-mediated site-directed mutagenesis or other site-directed mutagenesis protocols.
The Ste20-like polypeptide or homologue thereof may also be a derivative. “Derivatives” include peptides, oligopeptides, polypeptides, proteins and enzymes which may comprise substitutions, deletions or additions of naturally and non-naturally occurring amino acid residues compared to the amino acid sequence of a naturally-occurring form of the protein, for example, as presented in SEQ ID NO: 2. “Derivatives” include peptides, oligopeptides, polypeptides which may, compared to the amino acid sequence of the naturally-occurring form of the protein, such as the one presented in SEQ ID NO: 2, comprise substitutions of amino acids with non-naturally occurring amino acid residues, or additions of non-naturally occurring amino acid residues. “Derivatives” of a protein also encompass peptides, oligopeptides, polypeptides which may comprise naturally occurring altered (glycosylated, acylated, ubiquinated, prenylated, phosphorylated, myristoylated, sulphated etc) or non-naturally altered amino acid residues compared to the amino acid sequence of a naturally-occurring form of the polypeptide. A derivative may also comprise one or more non-amino acid substituents or additions compared to the amino acid sequence from which it is derived, for example a reporter molecule or other ligand, covalently or non-covalently bound to the amino acid sequence, such as a reporter molecule which is bound to facilitate its detection, and non-naturally occurring amino acid residues relative to the amino acid sequence of a naturally-occurring protein. Derivatives of orthologues or paralogues of SEQ ID NO: 2 are further examples which may be suitable for use in the methods of the invention.
The Ste20-like polypeptide or homologue thereof may be encoded by a splice variant of a Ste20-like nucleic acid/gene. The term “splice variant” as used herein encompasses variants of a nucleic acid sequence in which selected introns and/or exons have been excised, replaced, displaced or added, or in which introns have been shortened or lengthened. Such variants will be ones in which the biological activity of the protein is substantially retained, this may be achieved by selectively retaining functional segments of the protein. Such splice variants may be found in nature or may be manmade. Methods for making such splice variants are known in the art. Preferred splice variants are splice variants of the nucleic acid encoding a polypeptide comprising the Ste20 signature sequence (SEQ ID NO: 6) and a N-terminal Ser/Thr kinase domain as defined above. Preferably, the Ste20-like polypeptide or a homologue thereof additionally comprises SEQ ID NO: 7, more preferably the Ste20-like polypeptide or a homologue thereof comprises one or more of the following: SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 10. Further preferred are splice variants of nucleic acids represented by SEQ ID NO: 1, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 and SEQ ID NO: 33. Most preferred is a splice variant of the nucleic acid represented by SEQ ID NO: 1.
Another nucleic acid variant useful in the methods of the invention is an allelic variant of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof as defined above, preferably an allelic variant of a nucleic acid encoding a Ste20-like polypeptide comprising the Ste20 signature sequence (SEQ ID NO: 6) and a N-terminal Ser/Thr kinase domain. Preferably, the Ste20-like polypeptide or a homologue thereof additionally comprises SEQ ID NO: 7, more preferably the Ste20-like polypeptide or a homologue thereof comprises one or more of the following: SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 10. Further preferred are allelic variants of nucleic acids represented by SEQ ID NO: 1, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 and SEQ ID NO: 33. Most preferred is an allelic variant of a nucleic acid as represented by SEQ ID NO: 1. Allelic variants exist in nature, and encompassed within the methods of the present invention is the use of these natural alleles. Allelic variants encompass Single Nucleotide Polymorphisms (SNPs), as well as Small Insertion/Deletion Polymorphisms (INDELs). The size of INDELs is usually less than 100 bp. SNPs and INDELs form the largest set of sequence variants in naturally occurring polymorphic strains of most organisms.
A further nucleic acid variant useful in the methods of the invention is a nucleic acid variant obtained by gene shuffling. Gene shuffling or directed evolution may also be used to generate variants of Ste20-like nucleic acids. This consists of iterations of DNA shuffling followed by appropriate screening and/or selection to generate variants of Ste20-like nucleic acids or portions thereof having a modified biological activity (Castle et al., (2004) Science 304(5674): 1151-4; U.S. Pat. Nos. 5,811,238 and 6,395,547).
Furthermore, site-directed mutagenesis may be used to generate variants of Ste20-like nucleic acids. Several methods are available to achieve site-directed mutagenesis; the most common being PCR based methods (Current Protocols in Molecular Biology. Wiley Eds.).
The Ste20-like nucleic acid or variant thereof may be derived from any natural or artificial source. The nucleic acid/gene or variant thereof may be isolated from a microbial source, such as yeast or fungi, or from a plant, algae or animal (including human) source. This nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. The nucleic acid is preferably of plant origin, whether from the same plant species (for example to the one in which it is to be introduced) or whether from a different plant species. The nucleic acid may be isolated from a dicotyledonous species, preferably from the family Brassicaceae, further preferably from Arabidopsis thaliana. More preferably, the Ste20-like nucleic acid is isolated from Arabidopsis thaliana and is represented by SEQ ID NO: 1, and the Ste20-like amino acid sequences is as represented by SEQ ID NO: 2.
According to a preferred aspect of the present invention, modulated, preferably increased expression of the Ste20-like nucleic acid or variant thereof is envisaged. Methods for increasing expression of genes or gene products are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression of a Ste20-like nucleic acid or variant thereof. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene. Methods for reducing the expression of genes or gene products are well documented in the art.
The expression of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof may be modulated by introducing a genetic modification (preferably in the locus of a Ste20-like gene). The locus of a gene as defined herein is taken to mean a genomic region, which includes the gene of interest and 10 kb up- or down stream of the coding region.
The genetic modification may be introduced by, for example, T-DNA activation, TILLING, or homologous recombination. Following introduction of the genetic modification, there follows a step of selecting for modified expression of a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof, which modification in expression gives plants having increased yield.
T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353) involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or down stream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through Agrobactedum infection and leads to overexpression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to overexpression of genes close to the introduced promoter. The promoter to be introduced may be any promoter capable of directing expression of a gene in the desired organism, in this case a plant. For example, constitutive, tissue-preferred, cell type-preferred and inducible promoters are all suitable for use in T-DNA activation.
A genetic modification may also be introduced in the locus of a Ste20-like gene using the technique of TILLING (Targeted Induced Local Lesions In Genomes). This is a mutagenesis technology useful to generate and/or identify (and to eventually isolate) mutagenised variants of a Ste20-like nucleic acid with modulated expression and/or activity. TILLING also allows selection of plants carrying such mutant variants. These mutant variants may exhibit modified expression, either in strength or in location or in timing (if the mutations affect the promoter for example). These mutant variants may even exhibit higher Ste20-like activity than that exhibited by the gene in its natural form. TILLING combines high-density mutagenesis with high-throughput screening methods. The steps typically followed in TILLING are: (a) EMS mutagenesis (Redei G P and Koncz C (1992) In Methods in Arabidopsis Research, Koncz C, Chua N H, Schell J, eds. Singapore, World Scientific Publishing Co, pp. 1682; Feldmann et al., (1994) In Meyerowitz E M, Somerville C R, eds, Arabidopsis. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., pp 137-172; Lightner J and Caspar T (1998) In J Martinez-Zapater, J Salinas, eds, Methods on Molecular Biology, Vol. 82. Humana Press, Totowa, N.J., pp 91-104); (b) DNA preparation and pooling of individuals; (c) PCR amplification of a region of interest; (d) denaturation and annealing to allow formation of heteroduplexes; (a) DHPLC, where the presence of a heteroduplex in a pool is detected as an extra peak in the chromatogram; (f) identification of the mutant individual; and (g) sequencing of the mutant PCR product. Methods for TILLING are well known in the art (McCallum et al., (2000) Nat Biotechnol 18: 455-457; reviewed by Stemple (2004) Nat Rev Genet 5(2): 145-50).
T-DNA activation and TILLING are examples of technologies that enable the generation of novel alleles and Ste20-like variants.
The effects of the invention may also be reproduced using homologous recombination, which allows introduction in a genome of a selected nucleic acid at a defined selected position. Homologous recombination is a standard technology used routinely in biological sciences for lower organisms such as yeast or the moss Physcomitrella. Methods for performing homologous recombination in plants have been described not only for model plants (Offring a et al. (1990) EMBO J 9(10): 3077-84) but also for crop plants, for example rice (Terada et al. (2002) Nat Biotech 20(10): 1030-4; lida and Terada (2004) Curr Opin Biotech 15(2):132-8). The nucleic acid to be targeted (which may be a Ste20-like nucleic acid or variant thereof as hereinbefore defined) need not be targeted to the locus of a Ste20-like gene, but may be introduced in, for example, regions of high expression. The nucleic acid to be targeted may be an improved allele used to replace the endogenous gene or may be introduced in addition to the endogenous gene.
A preferred method for introducing a genetic modification (which in this case need not be in the locus of a Ste20-like gene) is to introduce and express in a plant a nucleic acid encoding a Ste20-like polypeptide or a homologue thereof, as defined above. The nucleic acid to be introduced into a plant may be a full-length nucleic acid or may be a portion or a hybridising sequence as hereinbefore defined.
The invention also provides genetic constructs and vectors to facilitate introduction and/or expression of the nucleotide sequences useful in the methods according to the invention.
Therefore, there is provided a gene construct comprising:

    
    
        (i) a Ste20-like nucleic acid or variant thereof, as defined hereinabove;
        (ii) one or more control sequences capable of driving expression of the nucleic acid sequence of (i); and optionally
        (iii) a transcription termination sequence.
    
    


Constructs useful in the methods according to the present invention may be constructed using recombinant DNA technology well known to persons skilled in the art. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells.
Plants are transformed with a vector comprising the sequence of interest (i.e., a nucleic acid encoding a Ste20-like polypeptide or homologue thereof). The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). The terms “regulatory element”, “control sequence” and “promoter” are all used interchangeably herein and are to be taken in a broad context to refer to regulatory nucleic acid sequences capable of effecting expression of the sequences to which they are ligated. The term “promoter” typically refers to a nucleic acid control sequence located upstream from the transcriptional start of a gene and which is involved in recognising and binding of RNA polymerase and other proteins, thereby directing transcription of an operably linked nucleic add. Encompassed by the aforementioned terms are transcriptional regulatory sequences derived from a classical eukaryotic genomic gene (including the TATA box which is required for accurate transcription initiation, with or without a CCAAT box sequence) and additional regulatory elements (i.e. upstream activating sequences, enhancers and silencers) which alter gene expression in response to developmental and/or external stimuli, or in a tissue-specific manner. Also included within the term is a transcriptional regulatory sequence of a classical prokaryotic gene, in which case it may include a −35 box sequence and/or −10 box transcriptional regulatory sequences. The term “regulatory element” also encompasses a synthetic fusion molecule or derivative that confers, activates or enhances expression of a nucleic acid molecule in a cell, tissue or organ. The term “operably linked” as used herein refers to a functional linkage between the promoter sequence and the gene of interest, such that the promoter sequence is able to initiate transcription of the gene of interest.
Suitable promoters, which are functional in plants, are generally known. They may take the form of constitutive or inducible promoters. Suitable promoters can enable the development- and/or tissue-specific expression in multi-celled eukaryotes; thus, leaf-, root-, flower-, seed-, stomata-, tuber- or fruit-specific promoters may advantageously be used in plants.
Different plant promoters usable in plants are promoters such as, for example, the USP, the LegB4-, the DC3 promoter or the ubiquitin promoter from parsley.
A “plant” promoter comprises regulatory elements, which mediate the expression of a coding sequence segment in plant cells. Accordingly, a plant promoter need not be of plant origin, but may originate from viruses or microorganisms, in particular for example from viruses which attack plant cells.
The “plant” promoter can also originates from a plant cell, e.g. from the plant, which is transformed with the nucleic acid sequence to be expressed in the inventive process and described herein. This also applies to other “plant” regulatory signals, for example in “plant” terminators.
For expression in plants, the nucleic acid molecule must, as described above, be linked operably to or comprise a suitable promoter which expresses the gene at the right point in time and in a cell- or tissue-specific manner. Usable promoters are constitutive promoters (Benfey et al., EMBO J. 8 (1989) 2195-2202), such as those which originate from plant viruses, such as 35S CAMV (Franck et al., Cell 21 (1980) 285-294), 19S CaMV (see also U.S. Pat. No. 5,352,605 and WO 84/02913), 34S FMV (Sanger et al., Plant. Mol. Biol., 14, 1990: 433%), the parsley ubiquitin promoter, or plant promoters such as the Rubisco small subunit promoter described in U.S. Pat. No. 4,962,028 or the plant promoters PRP1 [Ward et al., Plant. Mol. Biol. 22 (1993)], SSU, PGEL1, OCS [Leisner (1988) Proc Natl Acad Sci USA 85(5): 2553-2557], lib4, usp, mas [Comai (1990) Plant Mol Biol 15 (3):373-381], STLS1, ScBV (Schenk (1999) Plant Mol Biol 39(6):1221-1230), B33, SAD1 or SAD2 (flax promoters, Jain et al., Crop Science, 39 (6), 1999: 1696-1701) or nos [Shaw et al. (1984) Nucleic Acids Res. 12(20):7831-7846]. Further examples of constitutive plant promoters are the sugarbeet V-ATPase promoters (WO 01/14572). Examples of synthetic constitutive promoters are the Super promoter (WO 95/14098) and promoters derived from G-boxes (WO 94/12015). If appropriate, chemical inducible promoters may furthermore also be used, compare EP-A 388186, EP-A 335528, WO 97/06268. Stable, constitutive expression of the proteins according to the invention a plant can be advantageous. However, inducible expression of the polypeptide of the invention is advantageous, if a late expression before the harvest is of advantage, as metabolic manipulation may lead to plant growth retardation.
The expression of plant genes can also be facilitated via a chemical inducible promoter (for a review, see Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are particularly suitable when it is desired to express the gene in a time-specific manner. Examples of such promoters are a salicylic acid inducible promoter (WO 95/19443), and abscisic acid-inducible promoter (EP 335 528), a tetracydin-inducible promoter (Gatz et al. (1992) Plant J. 2, 397-404), a cyclohexanol- or ethanol-inducible promoter (WO 93/21334) or others as described herein.
Other suitable promoters are those which react to biotic or abiotic stress conditions, for example the pathogen-induced PRP1 gene promoter (Ward et al., Plant. Mol. Biol. 22 (1993) 361-366), the tomato heat-inducible hsp80 promoter (U.S. Pat. No. 5,187,267), the potato chill-inducible alpha-amylase promoter (WO 96/12814) or the wound-inducible pinll promoter (EP-A0 375 091) or others as described herein.
Preferred promoters are in particular those which bring gene expression in tissues and organs, in seed cells, such as endosperm cells and cells of the developing embryo. Suitable promoters are the oilseed rape napin gene promoter (U.S. Pat. No. 5,608,152), the Vicia faba USP promoter (Baeumlein et al., Mol Gen Genet, 1991, 225 (3): 459-67), the Arabidopsis oleosin promoter (WO 98/45461), the Phaseolus vulgaris phaseolin promoter (U.S. Pat. No. 5,504,200), the Brassica Bce4 promoter (WO 91/13980), the bean arc5 promoter, the carrot DcG3 promoter, or the Legumin B4 promoter (LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2): 233-9), and promoters which bring about the seed-specific expression in monocotyledonous plants such as maize, barley, wheat, rye, rice and the like. Advantageous seed-specific promoters are the sucrose binding protein promoter (WO 00/26388), the phaseolin promoter and the napin promoter. Suitable promoters which must be considered are the barley Ipt2 or Ipt1 gene promoter (WO 95/15389 and WO 95/23230), and the promoters described in WO 99/16890 (promoters from the barley hordein gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat gliadin gene, the wheat glutelin gene, the maize zein gene, the oat glutelin gene, the sorghum kasirin gene and the rye secalin gene). Further suitable promoters are Amy32b, Amy 6-6 and Aleurain [U.S. Pat. No. 5,677,474], Bce4 (oilseed rape) [U.S. Pat. No. 5,530,149], glycinin (soya) [EP 571 741], phosphoenolpyruvate carboxylase (soya) [JP 06/62870], ADR12-2 (soya) [WO 98/08962], isocitrate lyase (oilseed rape) [U.S. Pat. No. 5,689,040] or α-amylase (barley) [EP 781 849]. Other promoters which are available for the expression of genes in plants are leaf-specific promoters such as those described in DE-A 19644478 or light-regulated promoters such as, for example, the pea petE promoter.
Further suitable plant promoters are the cytosolic FBPase promoter or the potato ST-LSI promoter (Stockhaus et al., EMBO J. 8, 1989, 2445), the Glycine max phosphoribosylpyrophosphate amidotransferase promoter (GenBank Accession No. U87999) or the node-specific promoter described in EP-A-0 249 676.
Advantageously, any type of promoter may be used to drive expression of the nucleic acid sequence. The promoter may be an inducible promoter, i.e. having induced or increased transcription initiation in response to a chemical, environmental or physical stimulus. An example of an inducible promoter is a stress-inducible promoter, i.e. a promoter activated when a plant is exposed to various stress conditions, or a pathogen-induced promoter. Additionally or alternatively, the promoter may be a tissue-preferred promoter, i.e. one that is capable of preferentially initiating transcription in certain tissues, such as the leaves, roots, seed tissue etc; or may be a ubiquitous promoter, which is active in substantially all tissues or cells of an organism, or the promoter may be developmentally regulated, thereby being active during certain developmental stages or in parts of the plant that undergo developmental changes. Promoters able to initiate transcription in certain tissues only are referred to herein as “tissue-specific”, similarly, promoters able to initiate transcription in certain cells only are referred to herein as “cell-specific”.
Preferably, the Ste20-like nucleic acid or variant thereof is operably linked to a constitutive promoter. A constitutive promoter is transcriptionally active during most, but not necessarily all, phases of its growth and development and under most environmental conditions in at least one cell, tissue or organ. A preferred constitutive promoter is a constitutive promoter that is also substantially ubiquitously expressed. Further preferably the promoter is derived from a plant, more preferably a monocotyledonous plant. Most preferred is use of a GOS2 promoter (from rice) (as used in the expression cassette of SEQ ID NO: 5). It should be clear that the applicability of the present invention is not restricted to the Ste20-like nucleic acid represented by SEQ ID NO: 1, nor is the applicability of the invention restricted to expression of a nucleic acid encoding a Ste20-like protein when driven by a GOS2 promoter. Examples of other constitutive promoters which may also be used to drive expression of a nucleic acid encoding a Ste20-like protein are shown in Table 2 below.







TABLE 2







Examples of constitutive promoters










Expression



Gene Source
Pattern
Reference





Actin
Constitutive
McElroy et al, Plant Cell, 2: 163-171,




1990


CAMV 35S
Constitutive
Odell et al, Nature, 313: 810-812, 1985


CaMV 19S
Constitutive
Nilsson et al., Physiol. Plant 100:




456-462, 1997


GOS2
Constitutive
de Pater et al, Plant J Nov; 2(6):




837-44, 1992


Ubiquitin
Constitutive
Christensen et al, Plant Mol. Biol. 18:




675-689, 1992


Rice
Constitutive
Buchholz et al, Plant Mol Biol. 25(5):


cyclophilin

837-43, 1994


Maize H3
Constitutive
Lepetit et al, Mol. Gen. Genet. 231:


histone

276-285, 1992


Actin 2
Constitutive
An et al, Plant J. 10(1); 107-121, 1996









Optionally, one or more terminator sequences (also a control sequence) may be used in the construct introduced into a plant. The term “terminator” encompasses a control sequence which is a DNA sequence at the end of a transcriptional unit which signals 3′ processing and polyadenylation of a primary transcript and termination of transcription. The terminator can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The terminator to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, less preferably from any other eukaryotic gene. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. Such sequences would be known or may readily be obtained by a person skilled in the art.
An intron sequence may also be added to the 5′ untranslated region or the coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold, Buchman and Berg, Mol. Cell biol. 8:4395-4405 (1988); Callis et al., Genes Dev. 1:1183-1200 (1987). Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. See generally, The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994).
Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art.
The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-ori and colE1.
For the detection and/or selection of the successful transfer of the nucleic acid sequences as depicted in the sequence protocol and used in the process of the invention, it is advantageous to use marker genes (=reporter genes). These marker genes enable the identification of a successful transfer of the nucleic acid molecules via a series of different principles, for example via visual identification with the aid of fluorescence, luminescence or in the wavelength range of light which is discernible for the human eye, by a resistance to herbicides or antibiotics, via what are known as nutritive markers (auxotrophism markers) or antinutritive markers, via enzyme assays or via phytohormones. Examples of such markers which may be mentioned are GFP (=green fluorescent protein); the luciferin/luceferase system, the β-galactosidase with its colored substrates, for example X-Gal, the herbicide resistances to, for example, imidazolinone, glyphosate, phosphinothricin or sulfonylurea, the antibiotic resistances to, for example, bleomycin, hygromycin, streptomycin, kanamycin, tetracyclin, chloramphenicol, ampicillin, gentamycin, geneticin (G418), spectinomycin or blasticidin, to mention only a few, nutritive markers such as the utilization of mannose or xylose, or antinutritive markers such as the resistance to 2-deoxyglucose. This list is a small number of possible markers. The skilled worker is very familiar with such markers. Different markers are preferred, depending on the organism and the selection method.
Therefore the genetic construct may optionally comprise a selectable marker gene. As used herein, the term “selectable marker” or “selectable marker gene” includes any gene that confers a phenotype on a cell in which it is expressed to facilitate the identification and/or selection of cells that are transfected or transformed with a nucleic add construct of the invention. Suitable markers may be selected from markers that confer antibiotic or herbicide resistance, that introduce a new metabolic trait or that allow visual selection. Examples of selectable marker genes include genes conferring resistance to antibiotics (such as nptII that phosphorylates neomycin and kanamycin, or hpt, phosphorylating hygromycin), to herbicides (for example bar which provides resistance to Basta; aroA or gox providing resistance against glyphosate), or genes that provide a metabolic trait (such as mana that allows plants to use mannose as sole carbon source). Visual marker genes result in the formation of colour (for example β-glucuronidase, GUS), luminescence (such as luciferase) or fluorescence (Green Fluorescent Protein, GFP, and derivatives thereof).
It is known of the stable or transient integration of nucleic acids into plant cells that only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene encoding for a selectable marker (as described above, for example resistance to antibiotics) is usually introduced into the host cells together with the gene of interest. Preferred selectable markers in plants comprise those, which confer resistance to an herbicide such as glyphosate or gluphosinate. Other suitable markers are, for example, markers, which encode genes involved in biosynthetic pathways of, for example, sugars or amino acids, such as β-galactosidase, ura3 or ilv2. Markers, which encode genes such as luciferase, gfp or other fluorescence genes, are likewise suitable. These markers and the aforementioned markers can be used in mutants in whom these genes are not functional since, for example, they have been deleted by conventional methods. Furthermore, nucleic acid molecules, which encode a selectable marker, can be introduced into a host cell on the same vector as those, which encode the polypeptides of the invention or used in the process or else in a separate vector. Cells which have been transfected stably with the nucleic acid introduced can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die).
Since the marker genes, as a rule specifically the gene for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process according to the invention for introducing the nucleic acids advantageously employs techniques which enable the removal, or excision, of these marker genes. One such a method is what is known as cotransformation. The cotransformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% of the transformants and above), both vectors. In case of transformation with Agrobacteria, the transformants usually receive only a part of the vector, the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase resource or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases, the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what are known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase, which removes the sequences located between the loxP sequences. If the marker gene is integrated between the loxP sequences, it is removed, once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria.
The present invention also encompasses plants obtainable by the methods according to the present invention. The present invention therefore provides plants obtainable by the method according to the present invention, which plants have introduced therein a Ste20-like nucleic acid or variant thereof.
The invention also provides a method for the production of transgenic plants having increased yield, comprising introduction and expression in a plant of a Ste20-like nucleic acid or a variant thereof as defined above.
For the purposes of the invention, “transgenic”, “transgene” or “recombinant” means with regard to, for example, a nucleic acid sequence, an expression cassette (=gene construct) or a vector comprising the nucleic acid sequence or an organism transformed with the nucleic acid sequences, expression cassettes or vectors according to the invention, all those constructions brought about by recombinant methods in which either

    a) the nucleic acid sequences according to the invention, or
    b) genetic control sequences which is operably linked with the nucleic acid sequence according to the invention, for example a promoter, or
    c) a) and b)

are not located in their natural genetic environment or have been modified by recombinant methods, it being possible for the modification to take the form of, for example, a substitution, addition, deletion, inversion or insertion of one or more nucleotide residues. The natural genetic environment is understood as meaning the natural genomic or chromosomal locus in the original plant or the presence in a genomic library. In the case of a genomic library, the natural genetic environment of the nucleic acid sequence is preferably retained, at least in part. The environment flanks the nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp, especially preferably at least 1000 bp, most preferably at least 5000 bp. A naturally occurring expression cassette—for example the naturally occurring combination of the natural promoter. of the nucleic acid sequences with the corresponding nucleic acid sequence encoding a polypeptide having kinase domains or a homologue of such polypeptide—becomes a transgenic expression cassette when this expression cassette is modified by non-natural, synthetic (“artificial”) methods such as, for example, mutagenic treatment. Suitable methods are described, for example, in U.S. Pat. No. 5,565,350 or WO 00/15815.



A transgenic plant for the purposes of the invention is therefore understood as meaning, as above, that the nucleic acids used in the method of the invention are not at their natural locus in the genome of said plant, it being possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also means that, while the nucleic adds according to the invention or used in the inventive method are at their natural position in the genome of a plant, the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression of the nucleic acids takes place. Preferred transgenic plants are mentioned herein.
Host plants for the nucleic acids or the vector used in the method according to the invention, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method.
More specifically, the present invention provides a method for the production of transgenic plants having increased yield, which method comprises:

    
    
        (i) introducing and expressing in a plant cell a Ste20-like nucleic acid or variant thereof; and
        (ii) cultivating the plant cell under conditions promoting plant growth and development.
    
    


The nucleic acid may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a preferred feature of the present invention, the nucleic acid is preferably introduced into a plant by transformation.
The term “introduction” or “transformation” as referred to herein encompasses the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer. Plant tissue capable of subsequent clonal propagation, whether by organogenesis or embryogenesis, may be transformed with a genetic construct of the present invention and a whole plant regenerated there from. The particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed. Exemplary tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem). The polynucleotide may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host genome. The resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art.
The transfer of foreign genes into the genome of a plant is called transformation. In doing this the methods described for the transformation and regeneration of plants from plant tissues or plant cells are utilized for transient or stable transformation. An advantageous transformation method is the transformation in planta. To this end, it is possible, for example, to allow the agrobacteria to act on plant seeds or to inoculate the plant meristem with agrobacteria. It has proved particularly expedient in accordance with the invention to allow a suspension of transformed agrobacteria to act on the intact plant or at least the flower primordia. The plant is subsequently grown on until the seeds of the treated plant are obtained (Clough and Bent, Plant J. (1998) 16, 735-743). To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Further advantageous transformation methods, in particular for plants, are known to the skilled worker and are described herein below.
Transformation of plant species is now a fairly routine technique. Advantageously, any of several transformation methods may be used to introduce the gene of interest into a suitable ancestor cell. Transformation methods include the use of liposomes, electroporation, chemicals that increase free DNA uptake, injection of the DNA directly into the plant, particle gun bombardment, transformation using viruses or pollen and microprojection. Methods may be selected from the calcium/polyethylene glycol method for protoplasts (Krens, F. A. et al., (1982) Nature 296, 72-74; Negrutiu I et al. (1987) Plant Mol Biol 8: 363-373); electroporation of protoplasts (Shillito R. D. et al. (1985) Bio/Technol 3, 1099-1102); microinjection into plant material (Crossway A et al., (1986) Mol. Gen Genet 202: 179-185); DNA or RNA-coated particle bombardment (Klein T M et al., (1987) Nature 327: 70) infection with (non-integrative) viruses and the like. Transgenic rice plants expressing a Ste20-like nucleic acid/gene are preferably produced via Agrobacterium-mediated transformation using any of the well known methods for rice transformation, such as described in any of the following: published European patent application EP 1198985 A1, Aldemita and Hodges (Planta 199: 612-617, 1996); Chan et al. (Plant Mol Biol 22 (3): 491-506, 1993), Hiei et al. (Plant J 6 (2): 271-282, 1994), which disclosures are incorporated by reference herein as if fully set forth. In the case of corn transformation, the preferred method is as described in either Ishida et al. (Nat. Biotechnol 14(6): 745-50, 1996) or Frame et al. (Plant Physiol 129(1): 13-22, 2002), which disclosures are incorporated by reference herein as if fully set forth. Said methods are further described by way of example in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225). The nucleic acids or the construct to be expressed is preferably cloned into a vector, which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711). Agrobacteria transformed by such a vector can then be used in known manner for the transformation of plants, in particular of crop plants such as by way of example tobacco plants, for example by bathing bruised leaves or chopped leaves in an agrobacterial solution and then culturing them in suitable media. The transformation of plants by means of Agrobacterium tumefaciens is described, for example, by Höfgen and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known inter alia from F. F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Wu, Academic Press, 1993, pp. 15-38.
Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant.
As mentioned Agrobacteria transformed with an expression vector according to the invention may also be used in the manner known per se for the transformation of plants such as experimental plants like Arabidopsis or crop plants, such as, for example, cereals, maize, oats, rye, barley, wheat, soya, rice, cotton, sugarbeet, canola, sunflower, flax, hemp, potato, tobacco, tomato, carrot, bell peppers, oilseed rape, tapioca, cassava, arrow root, tagetes, alfalfa, lettuce and the various tree, nut, and grapevine species, in particular oil-containing crop plants such as soya, peanut, castor-oil plant, sunflower, maize, cotton, flax, oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa beans, for example by bathing scarified leaves or leaf segments in an agrobacterial solution and subsequently growing them in suitable media.
In addition to the transformation of somatic cells, which then has to be regenerated into intact plants, it is also possible to transform the cells of plant meristems and in particular those cells which develop into gametes. In this case, the transformed gametes follow the natural plant development, giving rise to transgenic plants. Thus, for example, seeds of Arabidopsis are treated with agrobacteria and seeds are obtained from the developing plants of which a certain proportion is transformed and thus transgenic [Feldman, K A and Marks M D (1987). Mol Gen Genet 208:274-289; Feldmann K (1992). In: C Koncz, N-H Chua and J Shell, eds, Methods in Arabidopsis Research. Word Scientific, Singapore, pp. 274-289]. Alternative methods are based on the repeated removal of the influorescences and incubation of the excision site in the center of the rosette with transformed agrobacteria, whereby transformed seeds can likewise be obtained at a later point in time (Chang (1994). Plant J. 5: 551-558; Katavic (1994). Mol Gen Genet, 245: 363-370). However, an especially effective method is the vacuum infiltration method with its modifications such as the “floral dip” method. In the case of vacuum infiltration of Arabidopsis, intact plants under reduced pressure are treated with an agrobacterial suspension [Bechthold, N (1993). C R Acad Sci Paris Life Sci, 316: 1194-1199], while in the case of the “floral dip” method the developing floral tissue is incubated briefly with a surfactant-treated agrobacterial suspension [Clough, S J und Bent, A F (1998). The Plant J. 16, 735-743]. A certain proportion of transgenic seeds are harvested in both cases, and these seeds can be distinguished from nontransgenic seeds by growing under the above-described selective conditions. In addition the stable transformation of plastids is of advantages because plastids are inherited maternally is most crops reducing or eliminating the risk of transgene flow through pollen. The transformation of the chloroplast genome is generally achieved by a process, which has been schematically displayed in Klaus et al., 2004 [Nature Biotechnology 22 (2), 225-229]. Briefly the sequences to be transformed are cloned together with a selectable marker gene between flanking sequences homologous to the chloroplast genome. These homologous flanking sequences direct site specific integration into the plastome. Plastidal transformation has been described for many different plant species and an overview can be taken from Bock (2001) Transgenic plastids in basic research and plant biotechnology. J Mol Biol. 2001 Sep. 21; 312 (3):425-38 or Maliga, P (2003) Progress towards commercialization of plastid transformation technology. Trends Biotechnol. 21, 20-28. Further biotechnological progress has recently been reported in form of marker free plastid transformants, which can be produced by a transient cointegrated maker gene (Klaus et al., 2004, Nature Biotechnology 22(2), 225-229).
The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S. D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer.
Following DNA transfer and regeneration, putatively transformed plants may be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, or quantitiative PCR, all techniques being well known to persons having ordinary skill in the art.
The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques.
The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion).
The present invention clearly extends to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to the invention. The invention also includes host cells containing an isolated Ste20-like nucleic acid or variant thereof. Preferred host cells according to the invention are plant cells. The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, rhizomes, tubers and bulbs. The invention furthermore relates to products directly derived from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins.
The present invention also encompasses use of Ste20-like nucleic acids or variants thereof and use of Ste20-like polypeptides or homologues thereof.
One such use relates to improving the growth characteristics of plants, in particular in improving yield, especially seed yield. The seed yield may include one or more of the following: increased total weight of seeds, increased number of filled seeds and increased Harvest Index.
Ste20-like nucleic acids or variants thereof, or Ste20-like polypeptides or homologues thereof may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to a Ste20-like gene or variant thereof. The Ste20-like nucleic acids/genes or variants thereof, or Ste20-like polypeptides or homologues thereof may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having increased yield. The Ste20-like gene or variant thereof may, for example, be a nucleic acid as represented by any one of SEQ ID NO: 1, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 and SEQ ID NO: 33.
Allelic variants of a Ste20-like nucleic acid/gene may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called “natural” origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question, for example, different allelic variants of any one of SEQ ID NO: 1, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31 and SEQ ID NO: 33. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants, in which the superior allelic variant was identified, with another plant. This could be used, for example, to make a combination of interesting phenotypic features.
A Ste20-like nucleic acid or variant thereof may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of Ste20-like nucleic acids or variants thereof requires only a nucleic acid sequence of at least 15 nucleotides in length. The Ste20-like nucleic acids or variants thereof may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch E F and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the Ste20-like nucleic acids or variants thereof. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the nucleic acids may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the Ste20-like nucleic acid or variant thereof in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331).
The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art.
The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein).
In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask (1991) Trends Genet 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes.
A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods.
The methods according to the present invention result in plants having increased yield, as described hereinbefore. These advantageous growth characteristics may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to various stresses, traits modifying various architectural features and/or biochemical and/or physiological features.



DESCRIPTION OF FIGURES
The present invention will now be described with reference to the following figures in which:
FIG. 1 shows the typical domain structure of Ste20-like polypeptides. The N-terminal end of the protein comprises a Ser/Thr kinase domain. The most C-terminal domain (in light grey) has a coiled coil structure, which is usually but not always present.
FIG. 2 shows a binary vector p070, for expression in Oryza sativa of an Arabidopsis thaliana Ste20-like coding sequence under the control of a GOS2 promoter (internal reference PRO0129).
FIG. 3 details examples of sequences useful in performing the methods according to the present invention.



EXAMPLES
The present invention will now be described with reference to the following examples, which are by way of illustration alone. Unless otherwise stated, recombinant DNA techniques are performed according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R. D. D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK).
Example 1
Identification of Homologues of the Ste20-Like Protein of SEQ ID NO: 2 and Determination of their Similarity/Identity
Sequences (full length cDNA, ESTs or genomic) related to the nucleic acid sequence used in the methods of the present invention were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). This program is typically used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. The polypeptide encoded by the nucleic acid of the present invention was used with the TBLASTN algorithm, with default settings and the filter for ignoring low complexity sequences was set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflect the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some instances, the default parameters may be adjusted to modify the stringency of the search.
Rice sequences and EST sequences from various plant species may also be obtained from other databases, such as KOME (Knowledge-based Oryza Molecular biological Encyclopedia; Kikuchi et al., Science 301, 376-379, 2003), Sputnik (Rudd, S., Nucleic Acids Res., 33: D622-D627, 2005) or the Eukaryotic Gene Orthologs database (EGO, hosted by The Institute for Genomic Research). These databases are searchable with the BLAST tool. SEQ ID NO: 11 to SEQ ID NO: 34 are nucleic acid and protein sequences of homologues of SEQ ID NO: 2 and were obtained from the above-mentioned databases using SEQ ID NO: 2 as a query sequence.
Percentages of similarity and identity between the full-length sequences and the sequences of the kinase domains of Ste20-like proteins were determined using MatGAT (Matrix Global Alignment Tool) software (BMC Bioinformatics. 2003 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. Campanella J J, Bitincka L, Smalley J; software hosted by Ledion Bitincka). MatGAT software generates similarity/identity matrices for DNA or protein sequences without needing pre-alignment of the data. The program performs a series of pair-wise alignments using the Myers and Miller global alignment algorithm (with a gap opening penalty of 11, and a gap extension penalty of 1), calculates similarity and identity using for example Blosum 62 (for polypeptides), and then places the results in a distance matrix. Sequence similarity is shown in the bottom half of the dividing line and sequence identity is shown in the top half of the diagonal dividing line. The sequence of SEQ ID NO: 2 is indicated as number 1 in the matrix.
The kinase domains of the Ste20-like proteins were delineated using the SMART tool and the obtained sequences are listed in Table 3.







TABLE 3





list of the kinase domains in the various


SEQ ID Nos:
















SEQ ID NO: 2
YEIICKIGVGVSASVYKAICIPMNSMVVAIKAIDLDQ



SRADFDSLRRETKTMSLLSHPNILNAYCSFTVDRCLW



VVMPFMSCGSLHSIVSSSFPSGLPENCISVFLKETLN



AISYLHDQGHLHRDIKAGNILVDSDGSVKLADFGVSA



SIYEPVTSSSGTTSSSLRLTDIAGTPYWMAPEVVHSH



TGYGFKADIWSFGITALELAHGRPPLSHLPPLKSLLM



KITKRFHFSDYEINTSGSSKKGNKKFSKAFREHVGLC



LEQDPTKRPSAEKLLKHPFF


 


SEQ ID NO: 12
YKLYEEIGDGVSATVHRALCIPLNVVVAIKVLDLEKC



NNDLDGIRREVQTMSLINHPNVLQAHCSFTTGHQLWV



VMPYMAGGSCLHIIKSSYPDGFEEPVIATLLRETLKA



LVYLHAHGHIHRDVKAGNILLDSNGAVKLADFGVSAC



MFDTGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKAD



VWSFGITALELAHGHAPFSKYFPMKVLLMTLQNAPPG



LDYERDKRFSKAFKEMVGTCLVKDPKKRPTSEKLLKH



PFF


 


SEQ ID NO: 14
YELFEEVGEGVSATVYRARCIALNEIVAVKILDLEKC



RNDLETIRKEVHIMSLIDHPNLLKAHCSFIDSSSLWI



VMPYMSGGSCFHLMKSVYPEGLEQPIIATLLREVLKA



LVYLHRQGHIHRDVKAGNILIHSKGVVKLGDFGVSAC



MFDSGERMQTRNTFVGTPCWMAPEVMQQLDGYDFKYL



AHGHAPFSKYPPMKVLLMTLQNAPPRLDYDRDKKFSK



SFRELIAACLVKDPKKRPTAAKLLKHPFF


 


SEQ ID NO: 16
YEILEEIGDGVYRARCILLDEIVAIKIWNLEKCTNDL



ETIRKEVHRLSLIDHPNLLRVHCSFIDSSSLWIVMPF



MSCGSSLNIMKSVYPNGLEEPVIAILLREILKALVYL



HGLGHIHRNVKAGNVLVDSEGTVKLGDFEVSASMFDS



VERMRTSSENTFVGNPRRMAPEKDMQQVDGYDFKVDI



WSFGMTALELAHGHSPTTVLPLNLQNSPFPNYEEDTK



FSKSFRELVAACLIEDPEKRPTASQLLEYPFL


 


SEQ ID NO: 18
YTLYEFIGQGVSALVHRALCIPFDEVVAIKILDFERD



NCDLNNISREAQTMMLVDHPNVLKSHCSFVSDHNLWV



IMPYMSGGSCLHILKAAYPDGFEEAIIATILREALKG



LDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSAC



LFDSGDRQRTRNTFVGTPCWMAPEVMEQLHGYDFKAD



IWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAPPG



LDYERDKKFSRSFKQMIASCLVKDPSKRPSAKKLLKH



SFF


 


SEQ ID NO: 20
YKLMEEVGYGASAVVHRAIYLPTNEVVAIKSLDLDRC



NSNLDDIRREAQTMTLIDHPNVIKSFCSFAVDHHLWV



VMPFMAQGSCLHLMKAAYPDGFEEAAICSMLKETLKA



LDYLHRQGHIHRDVKAGNILLDDTGEIKLGDFGVSAC



LFDNGDRQRARNTFVGTPCWMAPEVLQPGSGYNSKAD



IWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG



LDYDRDKKFSKSFKELVALCLVKDQTKRPTAEKLLKH



SFF


 


SEQ ID NO: 22
YKLMEEIGHGASAVVYRAIYLPTNEVVAIKCLDLDRC



NSNLDDIRRESQTMSLIDHPNVIKSFCSFSVDHSLWV



VMPFMAQGSCLHLMKTAYSDGFEESAICCVLKETLKA



LDYLHRQGHIHRDVKAGNILLDDNGEIKLGDFGVSAC



LFDNGDRQRARNTFVGTPCWMAPEVLQPGNGYNSKAD



IWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG



LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH



SCF


 


SEQ ID NO: 24
YRLLCKIGSGVSAVVYKAACVPLGSAVVAIKAIDLER



SRANLDEVWREAKAMALLSHRNVLRAHCSFTVGSHLW



VVMPFMAAGSLHSILSHGFPDGLPEQCIAVVLRDTLR



ALCYLHEQGRIHRDIKAGNILVDSDGSVKLADFGVSA



SIYETAPSTSSAFSGPINHAPPPSGAALSSSCFNDMA



GTPYWMAPEVIHSHVGYGIKADIWSFGITALELAHGR



PPLSHLPPSKSMLMRITSRVRLEVDASSSSSEGSSSA



ARKKKKFSKAFKDMVSSCLCQEPAKRPSAEKLLRHPF



F


 


SEQ ID NO: 26
YKLCEEVGDGVSATVYKALCIPLNIEVAIKVLDLEKC



SNDLDGIRREVQTMSLIDHPNLLRAYCSFTNGHQLWV



IMPYMAAGSALHIMKTSFPDGFEEPVIATLLREVLKA



LVYLHSQGHIHRDVKAGNILIDTNGAVKLGDFGVSAC



MFDTGNRQRARNTFVGTPCWMAPEVMQQLHGYDYKAD



IWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG



LDYERDKRFSKSFKDLVATCLVKDPRKRPSSEKLLKH



SFF


 


SEQ ID NO: 28
YELYEEIGQGVSAIVYRSLCKPLDEIVAVKVLDFERT



NSDLWLVVMQVGYTRIVAIYVPPLDLSKMIVTRICLT



QNNIMREAQTMILIDQPNVMKAHCSFTNNHSLWVVMP



YMAGGSCLHIMKSVYPDGFEEAVIATVLREVLKGLEY



LHHHGHIHRDVKAGNILVDSRGVVKLGDFGVSACLFD



SGDRQRARNTFVGTPCWMAPEVMEQLHGYDFKADIWS



FGITALELAHGHAPFSKFPPMKVLLMTLQNAPPGLDY



ERDKKFSRHFKQMVAMCLVKDPSKRPTAKKLLKQPFF


 


SEQ ID NO: 30
YQLMEEVGYGAHAVVYRALFVPRNDVVAVKCLDLDQL



NNNIDEIQREAQIMSLIEHPNVIRAYCSFVVEHSLWV



VMPFMTEGSCLHLMKIAYPDGFEEPVIGSILKETLKA



LEYLHRQGQIHRDVKAGNILVDNAGIVKLGDFGVSAC



MFDRGDRQRSRNTFVGTPCWMAPEVLQPGTGYNFKAD



IWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG



LDYDRDRRFSKSFKEMVAMCLVKDQTKRPTAEKLLKH



SFF


 


SEQ ID NO: 32
YRLLEEVGYGANAVVYRAVFLPSNRTVAVKCLDLDRV



NSNLDDIRKEAQTMSLIDHPNVIRAYCSFVVDHNLWV



IMPFMSEGSCLHLMKVAYPDGFEEPVIASILKETLKA



LEYLHRQGHIHRDVKRNIIQAGNILMDSPGIVKLGDF



GVSACMFDRGDRQRSRNTFVGTPCWMAPEVLQPGAGY



NFKKYVSNHLFTNLIWLFKISLRGKNSNYHKNTGNKV



LLMTLQNAPPGLDYDRDKRFSKSFKEMVAMCLVKDQT



KRPTAEKLLKHSFF


 


SEQ ID NO: 34
YKIVDEIGAGNSAVVYKAICIPINSTPVAIKSIDLDR



SRPDLDDVRREAKTLSLLSHPNILKAHCSFTVDNRLW



VVMPFMAGGSLQSIISHSFQNGLTEQSIAVILKDTLN



ALSYLHGQGHLHRDIKSGNILVDSNGLVKLADFGVSA



SIYESNNSVGACSSYSSSSSNSSSSHIFTDFAGTPYW



MAPEVIHSHNGYSFKADIWSFGITALELAHGRPPLSH



LPPSKSLMLNITKRFKFSDFDKHSYKGHGGSNKFSKA



FKDMVALCLNQDPTKRPSAEKLLKHSFF









Results of the MATGAT analysis are shown in Table 4 for the full-length sequences and in Table 5 for the kinase domains of the Ste20-like polypeptides. Percentage identity is given above the diagonal (in bold) and percentage similarity is given below the diagonal (normal font). Percentage identity between kinase domains of Ste20-like paralogues and orthologues of SEQ ID NO: 2 ranges between 44% (for SEQ ID NO: 28) and 71% (for SEQ ID NO: 34).







TABLE 4







Sequence similarity\identity for the full-length sequences





















1
2
3
4
5
6
7
8
9
10
11
12
13





1. SEQIDNO2

30.7
30.2
32.6
29.3
28.8
28.9
46.5
29.0
26.8
35.5
28.9
53.5


2. SEQIDNO12
45.8

45.3
33.9
45.2
42.8
43.1
28.6
55.1
42.7
41.5
38.3
32.3


3. SEQIDNO14
48.3
62.3

41.2
39.6
37.9
38.7
28.1
44.3
37.2
40.3
35.7
30.1


4. SEQIDNO16
55.2
48.1
56.4

28.9
27.4
27.8
30.7
33.7
29.2
35.8
30.1
32.8


5. SEQIDNO18
43.9
63.4
56.8
43.7

41.5
40.5
27.1
42.3
48.9
37.9
36.4
28.7


6. SEQIDNO20
42.1
61.2
53.8
41.9
61.4

73.9
26.8
41.2
40.2
45.2
47.7
29.8


7. SEQIDNO22
42.3
60.8
53.2
41.9
60.8
84.9

25.7
41.2
39.7
44.1
48.5
29.2


8. SEQIDNO24
59.9
43.9
48.1
47.8
41.6
42.7
41.9

28.3
26.3
32.2
26.9
47.1


9. SEQIDNO26
44.2
72.4
58.2
47.5
62.8
61.0
60.4
44.3

41.1
39.8
35.9
29.2


10. SEQIDNO28
39.3
57.7
51.5
41.7
64.9
58.6
56.4
39.3
58.6

36.8
34.2
25.9


11. SEQIDNO30
51.6
54.5
58.1
52.5
52.2
57.5
56.4
50.8
52.4
49.4

48.0
33.0


12. SEQIDNO32
42.8
54.9
51.8
42.9
53.9
64.1
63.0
43.9
54.5
51.1
60.9

29.3


13. SEQIDNO34
69.3
48.2
50.5
53.9
44.8
44.6
45.3
63.5
45.0
41.5
53.4
48.2
















TABLE 5







Sequence similarity\identity for the kinase domain sequences of Table 3





















1
2
3
4
5
6
7
8
9
10
11
12
13





1. SEQIDNO2

54.5
46.6
46.5
48.7
50.9
51.3
66.0
52.3
44.1
51.3
43.4
70.8


2. SEQIDNO12
69.9

72.5
60.5
77.5
74.0
74.4
50.2
86.6
70.3
74.4
64.5
52.3


3. SEQIDNO14
62.4
84.7

65.8
67.6
64.9
64.5
41.9
72.1
61.8
65.3
60.1
43.2


4. SEQIDNO16
65.2
77.9
82.3

54.5
52.3
52.6
40.9
59.8
51.3
53.8
49.1
44.8


5. SEQIDNO18
65.2
89.3
81.7
73.3

73.7
72.1
45.8
74.4
73.3
69.1
61.6
47.7


6. SEQIDNO20
67.4
86.3
78.2
72.9
87.0

93.1
47.0
73.3
63.9
81.3
72.5
51.9


7. SEQIDNO22
67.4
86.3
77.9
72.9
85.9
97.3

47.0
73.3
64.5
81.3
72.1
52.6


8. SEQIDNO24
77.1
64.6
59.3
58.9
60.9
62.3
62.0

49.2
43.2
47.0
39.9
64.4


9. SEQIDNO26
68.5
96.2
84.0
78.6
87.0
86.6
87.0
64.0

67.2
73.3
64.1
51.6


10. SEQIDNO28
62.8
79.1
73.0
66.2
81.8
76.7
76.7
61.3
78.0

63.2
55.5
43.0


11. SEQIDNO30
66.3
85.5
80.2
74.0
86.3
93.5
92.7
62.0
85.9
75.7

77.2
49.1


12. SEQIDNO32
62.0
78.0
72.9
66.7
78.8
85.0
83.9
57.9
78.8
71.6
87.2

44.4


13. SEQIDNO34
80.5
69.0
61.3
64.5
65.9
69.3
69.3
76.4
68.6
64.9
67.9
66.2









Example 2
Gene Cloning of Ste20-Like
The Arabidopsis thaliana Ste20-like gene was amplified by PCR using as template an Arabidopsis thaliana seedling cDNA library (Invtrogen, Paisley, UK). After reverse transcription of RNA extracted from seedlings, the cDNAs were cloned into pCMV Sport 6.0. Average insert size of the bank was 1.5 kb and the original number of clones was of the order of 1.59×107 cfu. Original titer was determined to be 9.6×105 cfu/ml after first amplification of 6×1011 cfu/ml. After plasmid extraction, 200 ng of template was used in a 50 μl PCR mix. Primers prm03186 (SEQ ID NO: 3; sense, start codon in bold, AttB1 site in italic: 5′-ggggacaagtttgtacaaaaaagcaggcttcacaatggctcggaacaagctc 3′) and prm03187 (SEQ ID NO: 4; reverse, complementary, AttB2 site in italic: 5′ ggggaccactttgtacaagaaagctgggtaatagttaacccaaaacactatcttta 3′), which include the AttB sites for Gateway recombination, were used for PCR amplification. PCR was performed using Hifi Taq DNA polymerase in standard conditions. A PCR fragment of 1532 bp (including attB sites) was amplified and purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombines in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an “entry done”, p068. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway® technology.
Example 3
Vector Construction
The entry done p068 were subsequently used in an LR reaction with p00640, a destination vector used for Oryza sativa transformation. This vector contains as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR in vivo recombination with the sequence of interest already doned in the entry done. A rice GOS2 promoter (nucleotides 1 to 2193 of SEQ ID NO: 5) for constitutive expression (PRO0129) was located upstream of this Gateway cassette.
After the LR recombination step, the resulting expression vector, p070 for Ste20-like (FIG. 2) was transformed into Agrobacterium strain LBA4044 and subsequently to Oryza sativa plants. Transformed rice plants were allowed to grow and were then examined for the parameters described in Example 4.
Example 4
Evaluation and Results of Step 20-Like Under the Control of the Rice GOS2 Promoter
Approximately 15 to 20 independent T0 rice transformants were generated. The primary transformants were transferred from a tissue culture chamber to a greenhouse for growing and harvest of T1 seed. Five events, of which the T1 progeny segregated 3:1 for presence/absence of the transgene, were retained. For each of these events, approximately 10 T1 seedlings containing the transgene (hetero- and homo-zygotes) and approximately 10 T1 seedlings lacking the transgene (nullizygotes) were selected by monitoring visual marker expression. The selected T1 plants were transferred to a greenhouse. Each plant received a unique barcode label to link unambiguously the phenotyping data to the corresponding plant. The selected T1 plants were grown on soil in 10 cm diameter pots under the following environmental settings: photoperiod=11.5 h, daylight intensity=30,000 lux or more, daytime temperature=28° C., night time temperature=22° C., relative humidity=60-70%. Transgenic plants and the corresponding nullizygotes were grown side-by-side at random positions. From the stage of sowing until the stage of maturity the plants were passed several times through a digital imaging cabinet. At each time point digital images (2048×1536 pixels, 16 million colours) were taken of each plant from at least 6 different angles.
The mature primary panicles were harvested, bagged, baroode-labelled and then dried for three days in the oven at 37° C. The panicles were then threshed and all the seeds collected. The filled husks were separated from the empty ones using an air-blowing device. After separation, both seed lots were then counted using a commercially available counting machine. The empty husks were discarded. The filled husks were weighed on an analytical balance and the cross-sectional area of the seeds was measured using digital imaging. This procedure resulted in the set of the following seed-related parameters:
The number of filled seeds was determined by counting the number of filled husks that remained after the separation step. The total seed yield was measured by weighing all filled husks harvested from a plant. Total seed number per plant was measured by counting the number of husks harvested from a plant. Thousand Kernel Weight (TKW) is extrapolated from the number of filled seeds counted and their total weight. Harvest index is defined as the ratio between the total seed weight and the above-ground area (mm2), multiplied by a factor 106. These parameters were derived in an automated way from the digital images using image analysis software and were analysed statistically. Individual seed parameters (including width, length, area, weight) were measured using a custom-made device consisting of two main components, a weighing and imaging device, coupled to software for image analysis.
A two factor ANOVA (analyses of variance) corrected for the unbalanced design was used as statistical model for the overall evaluation of plant phenotypic characteristics. An F-test was carried out on all the parameters measured of all the plants of all the events transformed with that gene. The F-test was carried out to check for an effect of the gene over all the transformation events and to verify for an overall effect of the gene, also named herein “global gene effect”. If the value of the F test shows that the data are significant, than it is concluded that there is a “gene” effect, meaning that not only presence or the position of the gene is causing the effect. The threshold for significance for a true global gene effect is set at 5% probability level for the F test.
To check for an effect of the genes within an event, i.e., for a line-specific effect, a t-test was performed within each event using data sets from the transgenic plants and the corresponding null plants. “Null plants” or “null segregants” or “nullizygotes” are the plants treated in the same way as the transgenic plant, but from which the transgene has segregated. Null plants can also be described as the homozygous negative transformed plants. The threshold for significance for the t-test is set at 10% probability level. The results for some events can be above or below this threshold. This is based on the hypothesis that a gene might only have an effect in certain positions in the genome, and that the occurrence of this position-dependent effect is not uncommon. This kind of gene effect is also named herein a “line effect of the gene”. The p-value is obtained by comparing the t-value to the t-distribution or alternatively, by comparing the F-value to the F-distribution. The p-value then gives the probability that the null hypothesis (i.e., that there is no effect of the transgene) is correct.
The data obtained for Ste20 in the first experiment were confirmed in a second experiment with T2 plants. Four lines that had the correct expression pattern were selected for further analysis. Seed batches from the positive plants (both hetero- and homozygotes) in T1, were screened by monitoring marker expression. For each chosen event, the heterozygote seed batches were then retained for T2 evaluation. Within each seed batch an equal number of positive and negative plants were grown in the greenhouse for evaluation.
A total number of 120 Ste20 transformed plants were evaluated in the T2 generation, that is 30 plants per event of which 15 positives for the transgene, and 15 negatives.
Because two experiments with overlapping events had been carried out, a combined analysis was performed. This is useful to check consistency of the effects over the two experiments, and if this is the case, to accumulate evidence from both experiments in order to increase confidence in the conclusion. The method used was a mixed-model approach that takes into account the multilevel structure of the data (i.e. experiment-event-segregants). P-values are obtained by comparing likelihood ratio test to chi square distributions.
Example 5
Evaluation of Ste20 Transformants: Measurement of Yield-Related Parameters
Upon analysis of the seeds as described above, the inventors found that plants transformed with the Ste20 gene construct had a higher seed yield, expressed as number of filled seeds, total weight of seeds and harvest index, compared to plants lacking the Ste20 transgene. The results obtained for plants in the T1 generation are summarised in Table 6:










TABLE 6







% difference
p-value




















Nr filled seeds
+38
0.0003



Total weight seeds
+38
0.0004



Harvest Index
+42
0.0001










These positive results were again obtained in the T2 generation. In Table 7, data show the overall % increases for the number of filled seeds, total weight of seeds and harvest index, calculated from the data of the individual lines of the T2 generation, and the respective p-values. These T2 data were re-evaluated in a combined analysis with the results for the T1 generation, and the obtained p-values show that the observed effects were highly significant.










TABLE 7









T2 generation
Combined analysis











% difference
p-value
p-value














Nr filled seeds
+30
0.0004
0.0000


Total weight seeds
+29
0.0008
0.0000


Harvest Index
+33
0.0001
0.0000

## Claims

1. A method for increasing plant seed yield relative to control plants, comprising introducing and expressing in a plant a Ste20-like nucleic acid or a variant thereof; and selecting a plant having increased seed yield compared to a control plant, wherein said Ste20-like nucleic acid or variant thereof encodes a polypeptide comprising the sequence of SEQ ID NO: 2 or a sequence having at least 95% sequence identity to the sequence of SEQ ID NO: 2 and wherein said Ste20-like nucleic acid or variant thereof is operably linked to a constitutive promoter.

2. The method according to claim 1, wherein said Ste20-like nucleic acid or variant thereof is overexpressed in a plant.

3. The method according to claim 1, wherein said Ste20-like nucleic acid or variant thereof is of plant origin.

4. The method according to claim 1, wherein said constitutive promoter is a GOS2 promoter.

5. The method according to claim 1, wherein said increased yield is selected from: increased total weight of seeds, increased number of filled seeds or increased harvest index.

6. A plant obtained by the method according to claim 1.

7. A method for the production of a transgenic plant having increased seed yield, which method comprises:
(i) introducing and expressing in a plant or plant cell a Ste20-like nucleic acid or variant thereof;
(ii) cultivating the plant cell under conditions promoting plant growth and development; and
(iii) selecting a plant having increased seed yield compared to a control plant, wherein said Ste20-like nucleic acid or variant thereof encodes a polypeptide comprising the sequence of SEQ ID NO: 2 or a sequence having at least 95% sequence identity to the sequence of SEQ ID NO: 2 and wherein said Ste20-like nucleic acid or variant thereof is operably linked to a constitutive promoter.

8. The method according to claim 7, wherein said variant is a portion of a Ste20-like nucleic acid or a sequence capable of hybridizing to a Ste20-like nucleic acid, which portion or hybridizing sequence encodes a polypeptide comprising a kinase domain and the Ste20 signature sequence of SEQ ID NO: 6.

9. A transgenic plant having increased seed yield compared to a control plant, which plant comprises a construct comprising a GOS2 promoter and a Ste20-like nucleic acid or a variant thereof, wherein said Ste20-like nucleic acid or variant thereof encodes a polypeptide comprising the sequence of SEQ ID NO: 2 or a sequence having at least 95% sequence identity to the sequence of SEQ ID NO: 2.

10. The transgenic plant according to claim 6, wherein said plant is a monocotyledonous plant.

11. Harvestable parts of the plant according to claim 6, wherein said harvestable parts comprise the nucleic acid.

12. Harvestable parts of a plant according to claim 11 wherein said harvestable parts are seeds.

13. A product directly derived from the plant according to claim 10 and/or from harvestable parts therefrom, wherein the product comprises the nucleic acid.

14. The method according to claim 1, wherein said Ste20-like nucleic acid or variant thereof is from a dicotyledonous plant.

15. The method according to claim 1, wherein said Ste20-like nucleic acid or variant thereof is from the family Brassicaceae.

16. The method according to claim 1, wherein said Ste20-like nucleic acid or variant thereof is from Arabidopsis thaliana.

17. The transgenic plant according to claim 7, wherein said plant is selected from the group consisting of sugar cane, rice, maize, wheat, barley, millet, rye, oats, and sorghum.

18. The transgenic plant according to claim 9, wherein said plant is a monocotyledonous plant.

19. Harvestable parts of the plant according to claim 9, wherein said harvestable parts comprise the nucleic acid.

20. Harvestable parts of a plant according to claim 19, wherein said harvestable parts are seeds.

21. A product directly derived from the plant according to claim 9, and/or from harvestable parts therefrom, wherein the product comprises the nucleic acid.

22. The transgenic plant according to claim 9, wherein said plant is selected from the group consisting of sugar cane, rice, maize, wheat, barley, millet, rye, oats, and sorghum.